Swift & Accurate
Prostate Cancer
Diagnosis
- Consultation to biopsy within 48 hours
- Fully in-clinic, no hospitalisation required
- Reduced waiting time and unnecessary costs
- Minimal discomfort in a safe, controlled environment
Did You Know?
A Prostate Biopsy Is the Most Reliable Way to Confirm Prostate Cancer
When there is a concern for prostate cancer, a biopsy gives you definitive answers. By taking small tissue samples from the prostate, your doctor can accurately determine whether cancer is present.
This allows your doctor to tailor a treatment plan to your diagnosis, helping you take the next step with confidence.
Prostate Biopsy Within 48 Hours. No Hospital Stay Required.
At Tan Urology, your biopsy is performed in-clinic, without the need for hospitalisation. From consultation to procedure, we streamline the process to get you clear answers sooner.
Why Patients Choose Us for Prostate Care
From assessment to diagnosis, your care is managed by Dr Lincoln Tan, a fellowship-trained urologist with access to advanced diagnostics and a coordinated, patient-focused approach.
Specialist Expertise You Can Trust
Advanced Prostate Cancer Risk Assessment
Comfortable In-House Facilities
Efficient Care That Saves You Time and Cost
A Clear Diagnosis Helps You Choose the Right Treatment Path
Whether your results show cancer, a benign condition or the need for monitoring, a prostate biopsy provides the information needed to make confident, informed decisions about your care.
A More Accurate, Safer Approach to Prostate Biopsies
At Tan Urology, we focus on giving you clear answers quickly by combining precise risk assessment with safer biopsy techniques to guide confident decisions.
Reducing Unnecessary Biopsies
Advanced Biopsy Techniques
Meet Our Prostate Specialist
Dr Lincoln Tan is a consultant urologist with a subspecialty focus in prostate cancer, with extensive experience in advanced diagnostics and prostate biopsy techniques. His approach centres on precise risk assessment and the use of safer, more accurate methods to guide treatment decisions.
Dr Tan was the principal investigator in the first local study validating the use of the Prostate Health Index (phi) test to improve risk identification for prostate cancer. He was also one of the clinical leads who introduced free-hand, office-based transperineal prostate biopsies into Singapore.
Beyond clinical practice, Dr Tan is an advocate for men’s health. He is actively involved in prostate cancer survivorship initiatives and contributes to the training and mentorship of future urology specialists.
Dr Lincoln Tan is a consultant urologist with a subspecialty focus in prostate cancer, with extensive experience in advanced diagnostics and prostate biopsy techniques. His approach centres on precise risk assessment and the use of safer, more accurate methods to guide treatment decisions.
Dr Tan was the principal investigator in the first local study validating the use of the Prostate Health Index (phi) test to improve risk identification for prostate cancer. He was also one of the clinical leads who introduced free-hand, office-based transperineal prostate biopsies into Singapore.
Beyond clinical practice, Dr Tan is an advocate for men’s health. He is actively involved in prostate cancer survivorship initiatives and contributes to the training and mentorship of future urology specialists.
